1 erstudied and together composed only 7% of the studies that
we considered.
2 We considered 10,314 unique orthologous protein families and
3 We considered 12 scenarios in which we varied GHGE targets [2
4 We considered 2 outcomes from the baseline wave of the Ten to
5 We considered 20 common presenting symptoms and examined thei
6 We considered 299 individuals (547 eyes) homozygous for risk
7 We considered 368 325 white British individuals from the UK B
8 We considered 4 IPV-related outcomes: reporting a controlling
9 We considered 509 consecutive patients with HCV cirrhosis (de
10 We considered 7 binary patient-level indicators of quality of
11 We considered 98,713 patients in 540 hospitals for colectomy
12 To analyze deviations from the inverse Gaussian model,
we considered a broader model set: the generalized inverse Ga
13 We considered a high-impact scenario and a low-impact scenari
14 We considered a key higher order role: tracking progress thro
15 We considered a response as either partial (PR) or complete r
16 keratometry (K(max)) at 12 months after cross-linking, and
we considered additional topographic, visual, and safety outc
17 Likewise, median OS was significantly different when
we considered all the response categories: complete or partia
18 We considered an adult population of people who inject drugs
19 We considered any outcome related to the critically ill patie
20 We considered articles reporting patients with TRb with survi
21 For these questions,
we considered bidirectionality, time of day, and differences
22 We considered correctly predicted contacts and compared their
23 en the markers of microbial exposure and disease onset, and
we considered for controls the same time window of exposures
24 For research purposes only,
we considered genes associated with neurological or psychiatr
25 Specifically,
we considered haplotype blocks in the gene ANGPTL4 for associ
26 However, when
we considered histologic findings of malignancy and follicula
27 Finally,
we considered how these novel laboratory tools might be trans
28 We considered permutations of testing (risk factor based, rou
29 We considered predicted outcomes over a 20-year period from 2
30 isoniazid (3HP) under various TTT scenarios. Specifically,
we considered rapidly scaling up TTT among people who are non
31 We considered scenarios in which disruptions affected 20%, 50
32 We considered scenarios of stronger (South Africa) and weaker
33 We considered scenarios that varied in the number of initial
34 r than traditional pairwise predator-prey diel comparisons,
we considered spatiotemporally explicit predator access to se
35 We considered studies that identified potential prognostic fa
36 We considered that an EC was present if: (1) the first pass a
37 We considered that FliI interacts with small GTPases and thei
38 no- or oligogenic variants for ischemic stroke, and second,
we considered that more common polygenic variants will be enr
39 Here,
we considered the complementary hypothesis that methylphenida
40 We considered the effect of different duration of cold exposu
41 We considered the formate channel from Vibrio cholerae, the h
42 We considered the possibility that the drug is a slow, tight-
43 Also,
we considered the relationship between right-left 2D:4D (Delt
44 For each setting scenario,
we considered the situation in 2018 and compared ART initiati
45 We considered this case to be of anaphylaxis caused by koayu
46 Here,
we considered this in the main olfactory epithelium, a chemos
47 We considered three reallocation scenarios representing the b
48 We considered three scenarios with different assumptions abou
49 We considered two expansion cohorts: parts B and D.
50 In this study
we considered whether participants could exert control and di